Back to top
more

CareDx (CDNA)

(Delayed Data from NSDQ)

$8.23 USD

8.23
448,610

+0.19 (2.36%)

Updated Apr 23, 2024 03:59 PM ET

After-Market: $8.22 -0.01 (-0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 252)

Industry: Medical Services

Better trading starts here.

Zacks News

Tenet Healthcare's (THC) Earnings Beat in Q3, Improve Y/Y

Tenet Healthcare's (THC) third-quarter earnings gain from the Ambulatory segment and lower expenses.

UnitedHealth's (UNH) Earnings in Q3 Beat on Higher Revenues

UnitedHealth's (UNH) Q3 earnings top estimates on solid revenues but the same was down year over year as health care utilization is resuming normalcy.

Here's Why CareDx (CDNA) is a Great Momentum Stock to Buy

Does CareDx (CDNA) have what it takes to be a top stock pick for momentum investors? Let's find out.

What's in the Offing for UnitedHealth (UNH) Earnings in Q3?

UnitedHealth's (UNH) Q3 results are likely to reflect a rise in revenues but a decline in earnings.

CareDx (CDNA) Q2 Earnings and Revenues Surpass Estimates

CareDx (CDNA) delivered earnings and revenue surprises of 166.67% and 17.69%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Will Cigna (CI) Keep the Beat Streak Alive in Q2 Earnings?

Cigna's (CI) business is likely to have been weighed down in Q2 due to high unemployment rate, partly offset by the delay in elective procedures resulting in lower claims.

5 Healthcare Stocks to Beat on Q2 Earnings Despite Coronavirus

Companies across the healthcare sector experience a mixed impact from coronavirus. While some gain traction from a surge in virtual care, the rest suffers demand woes and supply-chain glitches.

CareDx (CDNA) Reports Break-Even Earnings for Q1

CareDx (CDNA) delivered earnings and revenue surprises of -100.00% and 0.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: CareDx (CDNA) Q1 Earnings Expected to Decline

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Options Traders Betting on a Big Move in CareDx (CDNA) Stock?

Investors need to pay close attention to CareDx (CDNA) stock based on the movements in the options market lately.

The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx

The Zacks Analyst Blog Highlights: Smith Micro Software, Accuray, Vista Outdoor, Synaptics and CareDx

Nalak Das headshot

Trump Mulling Tax Cuts to Incentivize Stock Buying? 6 Picks

President Trump's tenure has seen Wall Street perform exceptionally well so far. In fact, Trump often cites Wall Street's bull run as a reflection of his good governance.

CareDx (CDNA) Upgraded to Strong Buy: Here's Why

CareDx (CDNA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

US Service Sector Accelerates in January: 5 Stocks to Buy

U.S. service sector and job market are flourishing, per January's ISM's non-manufacturing report. Investors can make the most by investing in the top-performing sectors.

The Zacks Analyst Blog Highlights: Calavo Growers, Darling Ingredients, The Simply Good Foods Company, KalVista Pharmaceuticals and CareDx

The Zacks Analyst Blog Highlights: Calavo Growers, Darling Ingredients, The Simply Good Foods Company, KalVista Pharmaceuticals and CareDx

5 Defensive Stocks to Counter Coronavirus Scare

Here are five defensive stocks that can shield your portfolio from China's coronavirus that intimidates to weigh on the stock market.

Tirthankar Chakraborty headshot

Super Bowl Results Show Stock Gains in February: 5 Picks

Markets have done well in years when AFL teams have won the Super Bowl than in years when the victors are from the NFL. With the Kansas City Chiefs winning this year, we can expect stocks to climb.

Sapna Bagaria headshot

Teladoc (TDOC) Hits 52-Week High: Will Momentum Sustain?

Teladoc (TDOC) stock gains from from positive earnings pre-announcement and news to acquire InTouch Health.

All You Need to Know About CareDx (CDNA) Rating Upgrade to Strong Buy

CareDx (CDNA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Top Ranked Momentum Stocks to Buy for October 18th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 18th

CareDx, Inc (CDNA) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in CareDx, Inc (CDNA).

CareDx (CDNA) Reports Next Week: Wall Street Expects Earnings Growth

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mitchell Moore headshot

Trump's Kidney Disease Executive Order May Boost This Health Stock, Tank Others

President Trump signed an executive order Wednesday that will encourage an increase in kidney transplants. This transplant diagnostic company stands to grow significantly, while dialysis companies will take a hit.

CareDx (CDNA) Q1 Earnings and Revenues Top Estimates

CareDx (CDNA) delivered earnings and revenue surprises of 350.00% and 7.07%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

CareDx (CDNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

CareDx (CDNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.